BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

644 related articles for article (PubMed ID: 18275004)

  • 1. Immunomodulatory lipids in plants: plant fatty acid amides and the human endocannabinoid system.
    Gertsch J
    Planta Med; 2008 May; 74(6):638-50. PubMed ID: 18275004
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pain and beyond: fatty acid amides and fatty acid amide hydrolase inhibitors in cardiovascular and metabolic diseases.
    Pillarisetti S; Alexander CW; Khanna I
    Drug Discov Today; 2009 Dec; 14(23-24):1098-111. PubMed ID: 19716430
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The enzymatic inactivation of the fatty acid amide class of signaling lipids.
    Cravatt BF; Lichtman AH
    Chem Phys Lipids; 2002 Dec; 121(1-2):135-48. PubMed ID: 12505696
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An introduction to the endocannabinoid system: from the early to the latest concepts.
    De Petrocellis L; Di Marzo V
    Best Pract Res Clin Endocrinol Metab; 2009 Feb; 23(1):1-15. PubMed ID: 19285257
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The endocannabinoid system: physiology and pharmacology.
    Rodríguez de Fonseca F; Del Arco I; Bermudez-Silva FJ; Bilbao A; Cippitelli A; Navarro M
    Alcohol Alcohol; 2005; 40(1):2-14. PubMed ID: 15550444
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The cannabinoid system and its pharmacological manipulation--a review, with emphasis upon the uptake and hydrolysis of anandamide.
    Fowler CJ
    Fundam Clin Pharmacol; 2006 Dec; 20(6):549-62. PubMed ID: 17109648
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Endocannabinoid biosynthesis and inactivation, from simple to complex.
    Muccioli GG
    Drug Discov Today; 2010 Jun; 15(11-12):474-83. PubMed ID: 20304091
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Endocannabinoid metabolism in the absence of fatty acid amide hydrolase (FAAH): discovery of phosphorylcholine derivatives of N-acyl ethanolamines.
    Mulder AM; Cravatt BF
    Biochemistry; 2006 Sep; 45(38):11267-77. PubMed ID: 16981687
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Endocannabinoids and endocannabinoid-related mediators: Targets, metabolism and role in neurological disorders.
    Iannotti FA; Di Marzo V; Petrosino S
    Prog Lipid Res; 2016 Apr; 62():107-28. PubMed ID: 26965148
    [TBL] [Abstract][Full Text] [Related]  

  • 10. N-acylethanolamine metabolism with special reference to N-acylethanolamine-hydrolyzing acid amidase (NAAA).
    Ueda N; Tsuboi K; Uyama T
    Prog Lipid Res; 2010 Oct; 49(4):299-315. PubMed ID: 20152858
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The emerging role of the endocannabinoid system in the sleep-wake cycle modulation.
    Murillo-Rodriguez E; Poot-Ake A; Arias-Carrion O; Pacheco-Pantoja E; Fuente-Ortegon Ade L; Arankowsky-Sandoval G
    Cent Nerv Syst Agents Med Chem; 2011 Sep; 11(3):189-96. PubMed ID: 21919868
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The endocannabinoid system in neurodegeneration.
    Battista N; Fezza F; Finazzi-Agrò A; Maccarrone M
    Ital J Biochem; 2006; 55(3-4):283-9. PubMed ID: 17274532
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The endocannabinoid system.
    Kilaru A; Chapman KD
    Essays Biochem; 2020 Sep; 64(3):485-499. PubMed ID: 32648908
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oxidation of the endogenous cannabinoid arachidonoyl ethanolamide by the cytochrome P450 monooxygenases: physiological and pharmacological implications.
    Snider NT; Walker VJ; Hollenberg PF
    Pharmacol Rev; 2010 Mar; 62(1):136-54. PubMed ID: 20133390
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Endocannabinoid system in frog and rodent testis: type-1 cannabinoid receptor and fatty acid amide hydrolase activity in male germ cells.
    Cobellis G; Cacciola G; Scarpa D; Meccariello R; Chianese R; Franzoni MF; Mackie K; Pierantoni R; Fasano S
    Biol Reprod; 2006 Jul; 75(1):82-9. PubMed ID: 16611862
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human adipose tissue binds and metabolizes the endocannabinoids anandamide and 2-arachidonoylglycerol.
    Spoto B; Fezza F; Parlongo G; Battista N; Sgro' E; Gasperi V; Zoccali C; Maccarrone M
    Biochimie; 2006 Dec; 88(12):1889-97. PubMed ID: 16949718
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The endocannabinoid system and migraine.
    Greco R; Gasperi V; Maccarrone M; Tassorelli C
    Exp Neurol; 2010 Jul; 224(1):85-91. PubMed ID: 20353780
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cannabinoids biology: the search for new therapeutic targets.
    Felder CC; Dickason-Chesterfield AK; Moore SA
    Mol Interv; 2006 Jun; 6(3):149-61. PubMed ID: 16809476
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of fatty acid amide hydrolase, a key endocannabinoid metabolizing enzyme, by analogues of ibuprofen and indomethacin.
    Holt S; Paylor B; Boldrup L; Alajakku K; Vandevoorde S; Sundström A; Cocco MT; Onnis V; Fowler CJ
    Eur J Pharmacol; 2007 Jun; 565(1-3):26-36. PubMed ID: 17397826
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Endocannabinoid tone versus constitutive activity of cannabinoid receptors.
    Howlett AC; Reggio PH; Childers SR; Hampson RE; Ulloa NM; Deutsch DG
    Br J Pharmacol; 2011 Aug; 163(7):1329-43. PubMed ID: 21545414
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 33.